German pharmaceutical companies are actively seeking collaboration opportunities in China, drawn by its rapid growth and significant presence in the global pharmaceutical sector. China, boasting over 10,000 major pharmaceutical firms as of November 2023 and ranking second in new drug research globally, presents an attractive market for German biomedical firms. These companies are enthusiastic about establishing a foothold in China's thriving pharmaceutical market.